Management Team

	Joseph D. Keegan, Ph.D. President and CEO Dr. Keegan has more than 25 years of experience managing life science tools businesses. During his 9-year tenure at Molecular Devices Corporation, Dr. Keegan grew the company’s revenues from $30 million to $190 million through internal growth and acquisitions. In early 2007, he oversaw its acquisition by MDS for $615 million. Dr. Keegan joined MDC from Becton Dickinson and Company where he served as President of Worldwide Tissue Culture and Vice President, General Manager of Worldwide Flow Cytometry. Prior to Becton Dickinson, Dr. Keegan was Vice President of the Microscopy and Scientific Instruments Division of Leica, Inc. He currently serves on the Board of Directors of ALSSA, BioImagene, Inc. and Seahorse Bioscience Inc. Dr. Keegan holds a Ph.D. in Physical Chemistry from Stanford University.
	Jack H. Fuchs Chief Financial Officer Jack brings a wide range of business and entrepreneurial skills to ForteBio including a deep understanding of marketing and sales, business development, finance and corporate strategy. As an entrepreneur, he has held Vice President, Marketing, Business Development, and Sales positions at a number of private companies, including IPWireless, a 120-person broadband wireless company that was successfully sold to a strategic buyer in 2007. Previously, Jack held several senior positions with increasing responsibility at Becton Dickinson & Company including Vice President, e-Business; North American Business Leader and Vice President Worldwide Marketing, Injection Systems; and Director of Corporate Planning. Earlier in his career, Jack was an Engagement Manager with McKinsey & Company, where his client focus was the healthcare industry, including technology strategy for pharmaceutical businesses and operational strategy for medical device businesses. He has an AB in Engineering Sciences from Dartmouth College and received his MBA from Stanford University.
	Terry L. Salyer Vice President of Sales Terry’s experience in the life sciences industry encompasses domestic sales, finance and marketing in addition to her leadership role in international sales. She joined ForteBio from Eksigent Technologies, where as Vice President of Worldwide Sales and Service Terry developed a global sales organization and commercial structure for this capital equipment company. Prior to that, as Director of Sales at Molecular Devices, Terry was responsible for the company’s Life Sciences, Cellular Neuroscience, and Threshold Divisions. During her ten years at Molecular Devices, Terry was also Western Regional Manager of the Life Sciences Division. She holds a BS in Biotechnology from Minnesota State University at Mankato.
	Christopher M. Silva Vice President, Marketing Chris brings to ForteBio a strong track record of product and business growth in the life sciences industry. Prior to joining ForteBio, he was Director of Strategic and Worldwide Product Marketing at Molecular Devices, a business unit of MDS, Inc. At Molecular Devices, he led three product families (including the SpectraMax microplate reader, the company’s largest product line), and doubled revenues to greater than $70 million in five years. Chris began his career as a founding member of Kairos Scientific Inc. He holds a BS in molecular biology from San Jose State University and an MBA from Santa Clara University. Chris holds four patents and is co-author of multiple peer-reviewed journal articles.
	Robert Wicke Vice President of Product Development and Operations Robert joined ForteBio in 2007 from Molecular Devices Corporation, where he was Vice President of Product Development, managing over 80 engineers. He was on the executive team there that helped the $615 million acquisition by MDS. Previously he was at Axon Instruments, Inc. as Vice President of Engineering, where he was part of the $170 million acquisition by Molecular Devices. In addition, Robert was a founding member of Anyware Fast, Inc., working closely with Sun Microsystems on creating the original Java platform and the XIL imaging suite. He has more than 20 years of professional software engineering experience, product development and over 10 years of executive business management in instrumentation companies; he has helped release over a dozen major successful products, including the Genepix microarray scanner, Axoclamp electrophysiology amplifiers and pClamp software, Metamorph for cellular imaging, Acuity for bioinformatics, and the FLIPR Tetra for fluorescence screening. Robert received a BA in Computer and Information Sciences and a BA in Mathematics from Drew University, NJ and an MS in Computer and Information Sciences, specializing in 3D mathematical visualization techniques from the University of Oregon.
	Lei Wu, Ph.D. Vice President, China Operations Dr. Wu brings strong leadership in both technology and business with extensive experience in strategy, management, operations, manufacturing, and international experience in the Chinese biotechnology market. Before he joined ForteBio, Dr. Wu co-founded AVIVA Biosciences in 1999 with technology transfer from Tsinghua University in China and held a variety of executive positions including COO, VP of system development and VP of manufacturing. Dr. Wu and his team developed planar patch-clamp technology which has won the award of Breakthrough Innovation in Science by BIOCOM in year 2002. Between 1995 and 1999, Dr. Wu worked at Nanogen where he was instrumental in the development of APEX biochip and instrument. He was responsible for development of the Lab-on-a-Chip at Nanogen that was published in Nature Biotechnology and selected as Breakthrough of the Year by SCIENCE magazine in 1998. He is inventor and or co-inventor on 18 issued patents, 12 pending patent applications and 32 publications. Dr. Wu received a Ph.D. in Physics from the University of Chicago and post-doctoral training at Massachusetts Institute Technology (MIT).